Peptide record

TPDB04449

C7A-Δ C7A Antibacterial Anticancer modified_plain modified
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB04449
C7A-Δ C7A
Antibacterial Anticancer
Anti-infective peptides Cancer-related peptides
AntiBP3 Peptipedia AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF
modified_plain
Yes
A 27-aa modified multi-activity (Antibacterial and Anticancer) peptide sequence curated from AntiBP3, Peptipedia, AntiCP 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
KILRGVAKKIMRTFLRRISKDILTGKK-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
27 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Antimicrobial Antitumor Activity
Synthetic peptide NK-2 peptide based derivatives Activity
Evidence Records 30 records
Evidence 1 Activity

Activity

IC50
IC50 =10.6 ± 0.4 µM
Anticancer
10.6

Target

Skin Cancer
E42/02
Skin

Assay & Model

MTT/MTS assay
30-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 =13.0 ± 1.0 µM
Anticancer
13.0

Target

Skin Cancer
E42/02
Skin

Assay & Model

MTT/MTS assay
2-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013
Evidence 3 Activity

Activity

IC50
IC50 =12.1 ± 1.6 µM
Anticancer
12.1

Target

Skin Cancer
E42/02
Skin

Assay & Model

MTT/MTS assay
4-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013
Evidence 4 Activity

Activity

IC50
IC50 =37 ± 4.3 µM
Anticancer
37

Target

Skin Cancer
E42/02
Skin

Assay & Model

MTT/MTS assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013
Evidence 5 Activity

Activity

Cell viability
Cell viability >50% at 25µM approx
Anticancer
>50 % at 25µM approx

Target

Colorectal Cancer
HCT-116
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 6 Activity

Activity

Cell viability
Cell viability >50% at 12.5µM approx.
Anticancer
>50 % at 12.5µM approx.

Target

Colorectal Cancer
HCT-116
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 7 Activity

Activity

Cell viability
Cell viability >60% at 25µM approx
Anticancer
>60 % at 25µM approx

Target

Colorectal Cancer
HROC24
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 8 Activity

Activity

Cell viability
Cell viability >60% at 25µM approx
Anticancer
>60 % at 25µM approx

Target

Colorectal Cancer
HROC24
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 9 Activity

Activity

Cell viability
Cell viability >60% at 25µM approx
Anticancer
>60 % at 25µM approx

Target

Colorectal Cancer
HROC40
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 10 Activity

Activity

Cell viability
Cell viability >50% at 25µM approx
Anticancer
>50 % at 25µM approx

Target

Colorectal Cancer
HROC40
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 11 Activity

Activity

Cell viability
Cell viability >50% at 25µM approx
Anticancer
>50 % at 25µM approx

Target

Colorectal Cancer
HROC60
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 12 Activity

Activity

Cell viability
Cell viability >50% at 25µM approx
Anticancer
>50 % at 25µM approx

Target

Colorectal Cancer
HROC60
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 13 Activity

Activity

Cell viability
Cell viability >60% at 25µM approx
Anticancer
>60 % at 25µM approx

Target

Colorectal Cancer
HROC32
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 14 Activity

Activity

Cell viability
Cell viability =50% at 12.5µM approx.
Anticancer

Target

Colorectal Cancer
HROC32
Colon

Assay & Model

Cell Viability assay
1-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 15 Activity

Activity

Cell viability
Cell viability >40% at 12.5µM approx
Anticancer
>40 % at 12.5µM approx

Target

Colorectal Cancer
HCT-116
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 16 Activity

Activity

Cell viability
Cell viability >50% at 12.5µM approx
Anticancer
>50 % at 12.5µM approx

Target

Colorectal Cancer
HCT-116
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 17 Activity

Activity

Cell viability
Cell viability >55% at 12.5µM approx
Anticancer
>55 % at 12.5µM approx

Target

Colorectal Cancer
HROC18
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 18 Activity

Activity

Cell viability
Cell viability >75% at 12.5µM approx
Anticancer
>75 % at 12.5µM approx

Target

Colorectal Cancer
HROC18
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 19 Activity

Activity

Cell viability
Cell viability >55% at 12.5µM approx
Anticancer
>55 % at 12.5µM approx

Target

Colorectal Cancer
HROC24
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 20 Activity

Activity

Cell viability
Cell viability >70% at 12.5µM approx
Anticancer
>70 % at 12.5µM approx

Target

Colorectal Cancer
HROC24
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 21 Activity

Activity

Cell viability
Cell viability >45% at 12.5µM approx
Anticancer
>45 % at 12.5µM approx

Target

Colorectal Cancer
HROC40
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 22 Activity

Activity

Cell viability
Cell viability >85% at 12.5µM approx
Anticancer
>85 % at 12.5µM approx

Target

Colorectal Cancer
HROC40
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 23 Activity

Activity

Cell viability
Cell viability >70% at 12.5µM approx
Anticancer
>70 % at 12.5µM approx

Target

Colorectal Cancer
HROC60
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 24 Activity

Activity

Cell viability
Cell viability >70% at 12.5µM approx
Anticancer
>70 % at 12.5µM approx

Target

Colorectal Cancer
HROC60
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 25 Activity

Activity

Cell viability
Cell viability >80% at 12.5µM approx
Anticancer
>80 % at 12.5µM approx

Target

Colorectal Cancer
HROC113
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 26 Activity

Activity

Cell viability
Cell viability >70% at 12.5µM approx
Anticancer
>70 % at 12.5µM approx

Target

Colorectal Cancer
HROC113
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 27 Activity

Activity

Cell viability
Cell viability >55% at 12.5µM approx
Anticancer
>55 % at 12.5µM approx

Target

Colorectal Cancer
HROC32
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 28 Activity

Activity

Cell viability
Cell viability >85% at 12.5µM approx
Anticancer
>85 % at 12.5µM approx

Target

Colorectal Cancer
HROC32
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 29 Activity

Activity

Cell viability
Cell viability >50% at 12.5µM approx
Anticancer
>50 % at 12.5µM approx

Target

Colorectal Cancer
HROC107
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014
Evidence 30 Activity

Activity

Cell viability
Cell viability >70% at 12.5µM approx
Anticancer
>70 % at 12.5µM approx

Target

Colorectal Cancer
HROC107
Colon

Assay & Model

Cell Viability assay
24-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2014